The effect of psychosocial and healthcare interventions on reducing hospitalization in people with dementia: an umbrella review.

TL;DR

An umbrella review of 25 systematic reviews found high-certainty evidence that case management and exercise programs do not reduce hospitalizations in dementia, but low-certainty evidence that advance care planning and moderate-certainty evidence that clinical pharmacists in multidisciplinary teams may help .

What the Study Found

Hospitalizations are a major burden for people with dementia and their caregivers. Compared to individuals without dementia, people with dementia face higher hospitalization rates, longer hospital stays, and greater complications from acute care settings. Yet despite decades of intervention research, it remains unclear which approaches actually reduce these hospitalizations. This umbrella review, published in Alzheimer's and Dementia, synthesized evidence from 25 systematic reviews encompassing 77 unique studies and nearly 1.5 million participants to answer this critical question.

The findings reveal a sobering reality: many interventions that seem promising in theory show limited real-world impact on hospitalization rates. Case management, a cornerstone of dementia care coordination, produced no significant reduction in hospitalizations despite widespread implementation . Exercise programs, despite their documented benefits for cognitive and physical function, similarly showed no effect on reducing hospital admissions . These negative findings are important because they represent high-certainty evidence, meaning the reviewers had substantial confidence in these conclusions based on multiple well-designed studies.

The more encouraging findings involve targeted interventions with narrower scope. Advance care planning conversations and documentation showed low-certainty evidence of reducing hospital admissions. This approach focuses on clarifying patients' values, preferences, and goals of care before crises occur, potentially preventing unnecessary hospitalizations driven by unclear decision-making. The second potentially beneficial intervention was the integration of clinical pharmacists into multidisciplinary teams, which demonstrated moderate-certainty evidence for reducing medication-related hospital readmissions . This finding highlights a specific harm prevention pathway: medications represent a major cause of preventable adverse events in older adults with dementia, and expert medication review appears to address this vulnerability.

Notably, the umbrella review found insufficient evidence for many other psychosocial and healthcare interventions. The authors were transparent that their positive findings remain modest in strength, with advance care planning at low-certainty and clinical pharmacist integration at moderate-certainty. This evidence gap exists despite substantial research effort. The reviewers emphasize that high-quality randomized controlled trials remain necessary to move from these preliminary indications toward confident clinical recommendations.

What This Means for You

If you are involved in dementia care planning, several practical considerations emerge from this evidence:

For hospital readmission prevention: If a person with dementia experiences medication-related complications or readmissions, ensuring a clinical pharmacist reviews their medication regimen as part of their care team may be worth prioritizing. This is one of the few interventions with measurable support in the literature.

For advance decision-making: Early conversations about values, goals of care, and treatment preferences appear more valuable than previously established for reducing unnecessary hospitalizations. These conversations work best when documented clearly and shared with all relevant healthcare providers. This reflects a shift from doing "more" to ensuring that care aligns with what the person actually wants.

For case management and exercise expectations: While case management and exercise have other documented benefits for cognition, mood, and physical function, the evidence does not support framing them primarily as hospitalization reduction strategies. Their value lies elsewhere, not in preventing acute care episodes.

For future caregiving decisions: The evidence gap itself is informative. Many interventions remain unproven, which means current best practice involves informed, individualized decision-making rather than proven protocols. Discussing specific concerns (medication safety, unclear goals of care, caregiver support) with your healthcare team allows targeted choices rather than generic programs with uncertain hospitalization benefits.

Study Details

Sources

Alzheimer's and Dementia. "The effect of psychosocial and healthcare interventions on reducing hospitalization in people with dementia: an umbrella review." PubMed. https://pubmed.ncbi.nlm.nih.gov/42473950